Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants
13/11/2025 22:26
Nov 13 (Reuters) - TELA Bio Inc TELA.O: TELA BIO ANNOUNCES PRICING OF $13.0 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS Source text: ID:nGNX9BMq4r Further company coverage: TELA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview